StonvexLoading…
StonvexStonvexStonvexCore line items from ASLE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $113.28M | $70.61M | $335.29M | $244.35M | $173.16M |
Operating Income | Not available | $-3.33M | $15.79M | $8.74M | $5.87M |
Net Income | Not available | $-3.45M | $8.57M | $3.18M | $8.57M |
EPS (Diluted) | $0.20 | $-0.07 | $0.18 | $0.06 | $0.07 |
Total Assets | Not available | $668.07M | $640.47M | $646.28M | $646.67M |
Total Liabilities | Not available | $245.28M | $216.04M | $229.19M | $230.76M |
Cash & Equivalents | Not available | $2.08M | $4.38M | $5.27M | $5.75M |
Free Cash Flow OCF − CapEx | Not available | $-27.71M | $-29.05M | $-38.83M | $-29.02M |
Shares Outstanding | Not available | 47.24M | 47.22M | 47.19M | 47.09M |